Liminatus Pharma, Inc.
Company Stats
- Market Cap
- $250.5M
- as of Sep 30, 2026
- Shares Outstanding
- 1.3M
- Free Float
- 100.0%
Income Statement
- Operating Income
- -$3.0M
- Net Income
- -$10.2M
- EBITDA
- -$3.0M
Cash Flow
- Free Cash Flow
- -$10.0M
- FCF Yield
- -4.0%
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$10.0M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.